The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Open accessAbstract
We previously showed that the availability of a nonamer peptide derived from certain HLA class I signal sequences is a necessary requirement for the stabilization of endogenous HLA-E expression on the surface of 721.221 cells. This led us to examine the ability of HLA-E to protect HLA class I transfectants from natural killer (NK) cell-mediated lysis. It was possible to implicate the CD94/NKG2A complex as an inhibitory receptor recognizing this class Ib molecule by using as target a .221 transfectant selectively expressing surface HLA-E. HLA-E had no apparent inhibitory effect mediated through the identified Ig superfamily (Ig-SF) human killer cell inhibitory receptors or ILT2/LIR1. Further studies of CD94/NKG2+ NK cell-mediated recognition of .221 cells transfected with different HLA class I allotypes (i.e., -Cw4, -Cw3, -B7) confirmed that the inhibitory interaction was mediated by CD94/NKG2A recognizing the surface HLA-E molecule, because only antibodies directed against either HLA-E, CD94, or CD94/NKG2A specifically restored lysis. Surface stabilization of HLA-E in cold-treated .221 cells loaded with appropriate peptides was sufficient to confer protection, resulting from recognition of the HLA class Ib molecule by the CD94/NKG2A inhibitory receptor. Consistent with the prediction that the ligand for CD94/NKG2A is expressed ubiquitously, our examination of HLA-E antigen distribution indicated that it is detectable on the surface of a wide variety of cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
Self-citationImplications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Self-citationIkeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Colonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., & Hsu, M.-L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80529-4 · Cited by 695
Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4951 · Cited by 505
Self-citationProtection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
Pazmany, L., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Reyburn, H. T., & Strominger, J. L. (1996) · Science · doi:10.1126/science.274.5288.792 · Cited by 497
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
Wei, M. L., & Cresswell, P. (1992) · Nature · doi:10.1038/356443a0 · Cited by 496
Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L., & Phillips, J. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4741 · Cited by 447
Cited by
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Natural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., & Velardi, A. (1999) · Blood · doi:10.1182/blood.v94.1.333.413a31_333_339 · Cited by 994
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N., & López-Botet, M. (2004) · Blood · doi:10.1182/blood-2004-05-2058 · Cited by 865
Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H., Lanier, L. L., Groh, V., Spies, T., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.020 · Cited by 855
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 825
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 726
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., & Wilkinson, G. W. G. (2000) · Science · doi:10.1126/science.287.5455.1031 · Cited by 661
Activation, coactivation, and costimulation of resting human natural killer cells
Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00457.x · Cited by 650
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559
HLA‐G and immune tolerance in pregnancy
Hunt, J. S., Petroff, M. G., McIntire, R. H., & Ober, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2078rev · Cited by 524
Regulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Human natural killer cell development and biology
Farag, S. S., & Caligiuri, M. A. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.10.001 · Cited by 506
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A., & Caligiuri, M. A. (2002) · Blood · doi:10.1182/blood-2002-02-0350 · Cited by 491
Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E., & Raulet, D. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1841 · Cited by 482
See no evil, hear no evil, do no evil: the lessons of immune privilege
Niederkorn, J. Y. (2006) · Nature Immunology · doi:10.1038/ni1328 · Cited by 447
Hsu, K. C., Chida, S., Geraghty, D. E., & Dupont, B. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19004.x · Cited by 443
Self-citationNatural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Hammer, Q., Rückert, T., Borst, E. M., Dunst, J., Haubner, A., Durek, P., Heinrich, F., Gasparoni, G., Babic, M., Tomic, A., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0082-6 · Cited by 423
Yee, C., Savage, P. A., Lee, P. P., Davis, M. M., & Greenberg, P. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2227 · Cited by 415
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Complex structure of the activating immunoreceptor NKG2D and its MHC class I–like ligand MICA
Li, P., Morris, D. L., Willcox, B. E., Steinle, A., Spies, T., & Strong, R. K. (2001) · Nature Immunology · doi:10.1038/87757 · Cited by 396
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N., & Raulet, D. H. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00003-1 · Cited by 394
Vales-Gomez, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.15.4250 · Cited by 384
Llano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E., & López-Botet, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2854::aid-immu2854>3.0.co;2-w · Cited by 382
Self-citationIshitani, A., Sageshima, N., Lee, N., Dorofeeva, N., Hatake, K., Marquardt, H., & Geraghty, D. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1376 · Cited by 377
Self-citationHLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
CAROSELLA, E. D., MOREAU, P., LE MAOULT, J., LE DISCORDE, M., DAUSSET, J., & ROUAS-FREISS, N. (2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81006-4 · Cited by 371
Navarro, F., Llano, M., Bellón, T., Colonna, M., Geraghty, D. E., & López-Botet, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<277::aid-immu277>3.0.co;2-4 · Cited by 366
Self-citationGeneration of hypoimmunogenic human pluripotent stem cells
Han, X., Wang, M., Duan, S., Franco, P. J., Kenty, J. H.-R., Hedrick, P., Xia, Y., Allen, A., Ferreira, L. M. R., Strominger, J. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902566116 · Cited by 363
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Kamiya, T., Seow, S. V., Wong, D., Robinson, M., & Campana, D. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123955 · Cited by 342
Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Yen, J.-H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M., & Goronzy, J. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1159 · Cited by 335
Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
HLA-G in human reproduction: aspects of genetics, function and pregnancy complications
Hviid, T. V. F. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi048 · Cited by 332
Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J., & Carosella, E. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5018 · Cited by 324
MHC class Ib molecules bridge innate and acquired immunity
Rodgers, J. R., & Cook, R. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1635 · Cited by 323
Reprogramming of CTLs into natural killer–like cells in celiac disease
Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L., Tretiakova, M., Semrad, C., Kistner, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060028 · Cited by 322
“In addition, its ligand HLA-E (32, 33) is strongly induced on celiac enterocytes, hence enabling full activation of intraepithelial NKG2C+ CTLs.”
BackgroundSelf-citationAllogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
Wang, X., Wu, X., Tan, B., Zhu, L., Zhang, Y., Lin, L., Xiao, Y., Sun, A., Wan, X., Liu, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.027 · Cited by 320
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
Le Gal, F.-A., Riteau, B., Sedlik, C., Khalil-Daher, I., Menier, C., Dausset, J., Guillet, J.-G., Carosella, E. D., & Rouas-Freiss, N. (1999) · International Immunology · doi:10.1093/intimm/11.8.1351 · Cited by 316
Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M., & Weiss, E. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5019 · Cited by 310
Strong, R. K., Holmes, M. A., Li, P., Braun, L., Lee, N., & Geraghty, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208268200 · Cited by 308
Self-citationEducation of human natural killer cells by activating killer cell immunoglobulin-like receptors
Fauriat, C., Ivarsson, M. A., Ljunggren, H.-G., Malmberg, K.-J., & Michaëlsson, J. (2010) · Blood · doi:10.1182/blood-2009-09-245746 · Cited by 305
Yokoyama, W. M. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80036-0 · Cited by 299
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293
Broadly targeted CD8 + T cell responses restricted by major histocompatibility complex E
Hansen, S. G., Wu, H. L., Burwitz, B. J., Hughes, C. M., Hammond, K. B., Ventura, A. B., Reed, J. S., Gilbride, R. M., Ainslie, E., Morrow, D. W., et al. (2016) · Science · doi:10.1126/science.aac9475 · Cited by 290
Béziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B., Theodorou, I., Martinot, M., Debré, P., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201141826 · Cited by 284
NK and NK/T cells in human senescence
Solana, R., & Mariani, E. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00495-8 · Cited by 278
Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans
Khakoo, S. I., Rajalingam, R., Shum, B. P., Weidenbach, K., Flodin, L., Muir, D. G., Canavez, F., Cooper, S. L., Valiante, N. M., Lanier, L. L., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80219-8 · Cited by 277
Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
Mandelboim, O., Malik, P., Davis, D. M., Jo, C. H., Boyson, J. E., & Strominger, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5640 · Cited by 275
A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition
Michaëlsson, J., Teixeira de Matos, C., Achour, A., Lanier, L. L., Kärre, K., & Söderström, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020797 · Cited by 272
Borrego, F., Kabat, J., Kim, D.-K., Lieto, L., Maasho, K., Peña, J., Solana, R., & Coligan, J. E. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00107-9 · Cited by 271
NK cells and ILCs in tumor immunotherapy
Sivori, S., Pende, D., Quatrini, L., Pietra, G., Della Chiesa, M., Vacca, P., Tumino, N., Moretta, F., Mingari, M. C., Locatelli, F., et al. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100870 · Cited by 270
Jabri, B., De Serre, N. P., Cellier, C., Evans, K., Gache, C., Carvalho, C., Mougenot, J., Allez, M., Jian, R., Desreumaux, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70173-9 · Cited by 261
“19 The selective induction of CD94 expression by celiac disease IELs also points to a specific function of the CD94 receptor and its ligand, the nonpolymorphic MHC class I molecule HLA-E, 31, 32, 48 in the immune processes associated with celiac disease.”
BackgroundShilling, H. G., McQueen, K. L., Cheng, N. W., Shizuru, J. A., Negrin, R. S., & Parham, P. (2003) · Blood · doi:10.1182/blood-2002-08-2568 · Cited by 257
IMMUNOLOGICAL RELATIONSHIP BETWEEN THE MOTHER AND THE FETUS
SZEKERES-BARTHO, J. (2002) · International Reviews of Immunology · doi:10.1080/08830180215017 · Cited by 257
Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2Chi Natural Killer Cells
Luetke-Eversloh, M., Hammer, Q., Durek, P., Nordström, K., Gasparoni, G., Pink, M., Hamann, A., Walter, J., Chang, H.-D., Dong, J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004441 · Cited by 256
HLA engineering of human pluripotent stem cells
Riolobos, L., Hirata, R. K., Turtle, C. J., Wang, P.-R., Gornalusse, G. G., Zavajlevski, M., Riddell, S. R., & Russell, D. W. (2013) · Molecular Therapy · doi:10.1038/mt.2013.59 · Cited by 253
Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory Pathway
Lu, L., Ikizawa, K., Hu, D., Werneck, M. B. F., Wucherpfennig, K. W., & Cantor, H. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.017 · Cited by 253
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Dubrot, J., Du, P. P., Lane-Reticker, S. K., Kessler, E. A., Muscato, A. J., Mehta, A., Freeman, S. S., Allen, P. M., Olander, K. E., Ockerman, K. M., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01315-x · Cited by 218
Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions
Brauning, A., Rae, M., Zhu, G., Fulton, E., Admasu, T. D., Stolzing, A., & Sharma, A. (2022) · Cells · doi:10.3390/cells11061017 · Cited by 215
E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I
Ashrafi, G. H., Haghshenas, M. R., Marchetti, B., O'Brien, P. M., & Campo, M. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.20558 · Cited by 192
Intraepithelial lymphocytes in celiac disease immunopathology
Abadie, V., Discepolo, V., & Jabri, B. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0316-x · Cited by 183
Manser, A. R., & Uhrberg, M. (2016) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-015-1750-0 · Cited by 148
TCR Specificity Dictates CD94/NKG2A Expression by Human CTL
Jabri, B., Selby, J. M., Negulescu, H., Lee, L., Roberts, A. I., Beavis, A., Lopez-Botet, M., Ebert, E. C., & Winchester, R. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00427-2 · Cited by 136
The paths and challenges of “off-the-shelf” CAR-T cell therapy: an overview of clinical trials
Moradi, V., Omidkhoda, A., & Ahmadbeigi, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115888 · Cited by 80
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
Zhao, W., Lei, A., Tian, L., Wang, X., Correia, C., Weiskittel, T., Li, H., Trounson, A., Fu, Q., Yao, K., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101162 · Cited by 53
Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells
Dietrich, J., Nakajima, H., & Colonna, M. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00294-x · Cited by 53
Endometrial gene expression in early pregnancy: Lessons from human ectopic pregnancy
Savaris, R. F., Hamilton, A. E., Lessey, B. A., & Giudice, L. C. (2008) · Reproductive Sciences · doi:10.1177/1933719108317585 · Cited by 37
MHC-E–Restricted CD8+ T Cells Target Hepatitis B Virus–Infected Human Hepatocytes
Burwitz, B. J., Hashiguchi, P. K., Mansouri, M., Meyer, C., Gilbride, R. M., Biswas, S., Womack, J. L., Reed, J. S., Wu, H. L., Axthelm, M. K., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900795 · Cited by 24
Podbielska, M., Levery, S. B., & Hogan, E. L. (2011) · Clinical Lipidology · doi:10.2217/clp.11.8 · Cited by 21
Metadata
- Authors
- Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-04-28
- Volume
- 95
- Issue
- 9
- Pages
- 5199-5204
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2014208459
- Cited by
- 1,053
- References
- 35
- FWCI
- 22.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.